Lidoderm® (Lidocaine Patch 5%) in Diabetic and Idiopathic Neuropathy
Clinical trial NCT00903851 · COMPLETED
Trial details
- NCT number
- NCT00903851
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-04-01
- Primary completion
- 2003-06-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.